• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征:一种常见的内分泌紊乱疾病及血管疾病的危险因素。

Polycystic ovary syndrome: a common endocrine disorder and risk factor for vascular disease.

作者信息

McGowan Mary P

机构信息

MEDPACE, Clinical Pharmacology, 4685 Forest Ave., Cincinnati, OH, 45212, USA,

出版信息

Curr Treat Options Cardiovasc Med. 2011 Aug;13(4):289-301. doi: 10.1007/s11936-011-0130-0.

DOI:10.1007/s11936-011-0130-0
PMID:21562798
Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among women of reproductive age, impacting 5-10% of premenopausal American women. During the reproductive years, women with PCOS seek medical attention related to infertility, hirsutism, and acne. About 60% of women with PCOS are obese and insulin resistant. Up to 40% of women with PCOS will develop diabetes by the age of 50 and many are dyslipidemic. In addition to treating the cosmetic and fertility issues associated with PCOS, health care providers must educate patients regarding the long-term cardiovascular consequences associated the this disorder. At menopause, a woman with PCOS is likely to have had multiple cardiac risk factors for several decades. Postmenopausal women with a history of PCOS, especially those with established diabetes and/or dyslipidemia, should be considered at high risk for the development of clinical cardiac disease. Exercise and a prudent calorie-restricted diet aimed at weight loss must be stressed early. Pharmacologic therapy for diabetes and hyperlipidemia should be used when appropriate. Bariatric surgery, known to positively impact all the aforementioned cardiac risk factors, may also be of benefit.

摘要

多囊卵巢综合征(PCOS)是育龄女性中最常见的内分泌疾病,影响着5%至10%的美国绝经前女性。在生育年龄段,患有PCOS的女性会因不孕、多毛症和痤疮而寻求医疗帮助。约60%的PCOS女性肥胖且存在胰岛素抵抗。高达40%的PCOS女性在50岁时会患糖尿病,许多人还存在血脂异常。除了治疗与PCOS相关的美容和生育问题外,医疗保健人员还必须就该疾病相关的长期心血管后果对患者进行教育。在绝经时,患有PCOS的女性可能已经有几十年的多种心脏危险因素。有PCOS病史的绝经后女性,尤其是那些已确诊患有糖尿病和/或血脂异常的女性,应被视为发生临床心脏病的高危人群。必须尽早强调通过运动和谨慎的热量限制饮食来减肥。必要时应使用糖尿病和高脂血症的药物治疗。已知对上述所有心脏危险因素都有积极影响的减肥手术可能也有益处。

相似文献

1
Polycystic ovary syndrome: a common endocrine disorder and risk factor for vascular disease.多囊卵巢综合征:一种常见的内分泌紊乱疾病及血管疾病的危险因素。
Curr Treat Options Cardiovasc Med. 2011 Aug;13(4):289-301. doi: 10.1007/s11936-011-0130-0.
2
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.美国临床内分泌医师协会、美国内分泌学会以及雄激素过多与多囊卵巢综合征协会疾病状态临床综述:多囊卵巢综合征评估与治疗最佳实践指南 - 第2部分。
Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2.
3
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.美国临床内分泌医师协会、美国内分泌学会以及雄激素过多与多囊卵巢综合征协会疾病状态临床综述:多囊卵巢综合征评估与治疗最佳实践指南——第1部分。
Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC.
4
Beyond fertility: polycystic ovary syndrome and long-term health.超越生育能力:多囊卵巢综合征与长期健康
Fertil Steril. 2018 Oct;110(5):794-809. doi: 10.1016/j.fertnstert.2018.08.021.
5
Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.噻唑烷二酮类药物用于多囊卵巢综合征的治疗管理:对代谢和生殖异常的影响
Treat Endocrinol. 2006;5(3):171-87. doi: 10.2165/00024677-200605030-00005.
6
Polycystic Ovary Syndrome.多囊卵巢综合征。
Obstet Gynecol. 2018 Aug;132(2):321-336. doi: 10.1097/AOG.0000000000002698.
7
Polycystic ovaries - beyond menopause.多囊卵巢——绝经后
Climacteric. 2014 Apr;17(2):109-15. doi: 10.3109/13697137.2013.828687. Epub 2013 Oct 28.
8
Polycystic ovary syndrome and metabolic comorbidities: therapeutic options.多囊卵巢综合征与代谢合并症:治疗选择
Drugs Today (Barc). 2009 Oct;45(10):763-75.
9
The role of obesity in the development of polycystic ovary syndrome.肥胖在多囊卵巢综合征发展中的作用。
Curr Pharm Des. 2012;18(17):2482-91. doi: 10.2174/13816128112092482.
10
Defining the role of bariatric surgery in polycystic ovarian syndrome patients.定义减重手术在多囊卵巢综合征患者中的作用。
World J Diabetes. 2012 Apr 15;3(4):71-9. doi: 10.4239/wjd.v3.i4.71.

引用本文的文献

1
Ovarian Torsion in Patients With Polycystic Ovary Syndrome Without Ovulation Induction or an Adnexal Mass: A Report of Two Cases.无排卵诱导或附件包块的多囊卵巢综合征患者的卵巢扭转:两例报告
Cureus. 2025 Jul 23;17(7):e88608. doi: 10.7759/cureus.88608. eCollection 2025 Jul.
2
Subclinical Hypothyroidism in Polycystic Ovary Syndrome: Prevalence and Impact on Metabolic and Cardiovascular risk.多囊卵巢综合征中的亚临床甲状腺功能减退:患病率及其对代谢和心血管风险的影响。
Clin Med Insights Endocrinol Diabetes. 2025 Jun 3;18:11795514251343678. doi: 10.1177/11795514251343678. eCollection 2025.
3
Health-related quality of life among Indian women with polycystic ovary syndrome: A cross-sectional study in Kolkata, West Bengal.

本文引用的文献

1
Trends and outcomes of adolescent bariatric surgery in California, 2005-2007.加利福尼亚州 2005-2007 年青少年减重手术的趋势和结果。
Pediatrics. 2010 Oct;126(4):e746-53. doi: 10.1542/peds.2010-0412. Epub 2010 Sep 20.
2
Cost-effectiveness of bariatric surgery for severely obese adults with diabetes.肥胖合并糖尿病患者行减重手术的成本效果分析。
Diabetes Care. 2010 Sep;33(9):1933-9. doi: 10.2337/dc10-0554.
3
Standards of medical care in diabetes--2010.《糖尿病医疗护理标准——2010》
印度多囊卵巢综合征女性的健康相关生活质量:西孟加拉邦加尔各答的一项横断面研究
Malays Fam Physician. 2025 Mar 4;20:14. doi: 10.51866/oa.550. eCollection 2025.
4
Implications of Non-compliance in the Management of Chronic Polycystic Ovarian Syndrome.慢性多囊卵巢综合征管理中不依从的影响
Cureus. 2025 Feb 23;17(2):e79501. doi: 10.7759/cureus.79501. eCollection 2025 Feb.
5
Understanding Pain in Polycystic Ovary Syndrome: Health Risks and Treatment Effectiveness.了解多囊卵巢综合征中的疼痛:健康风险与治疗效果
medRxiv. 2024 Oct 16:2024.10.15.24315513. doi: 10.1101/2024.10.15.24315513.
6
Available Treatments and Adjunctive Therapies for Polycystic Ovarian Syndrome (PCOS) Patients of Reproductive Age: A Scoping Review.育龄期多囊卵巢综合征(PCOS)患者的可用治疗方法及辅助治疗:一项范围综述
Cureus. 2024 Sep 30;16(9):e70501. doi: 10.7759/cureus.70501. eCollection 2024 Sep.
7
Circulating nesfatin-1 levels in women with polycystic ovary syndrome: A systematic review and meta-analysis.多囊卵巢综合征女性循环中核连蛋白-1水平:一项系统评价和荟萃分析。
Int J Reprod Biomed. 2023 Nov 24;21(10):777-788. doi: 10.18502/ijrm.v21i10.14533. eCollection 2023 Oct.
8
Ovarian Torsion in Polycystic Ovary Syndrome: A Potential Threat?多囊卵巢综合征中的卵巢扭转:一种潜在威胁?
Biomedicines. 2023 Sep 10;11(9):2503. doi: 10.3390/biomedicines11092503.
9
Knowledge, attitude, and perceptions about polycystic ovarian syndrome, and its determinants among Pakistani undergraduate students.多囊卵巢综合征相关知识、态度和认知及其在巴基斯坦本科生中的决定因素。
PLoS One. 2023 May 25;18(5):e0285284. doi: 10.1371/journal.pone.0285284. eCollection 2023.
10
Potential Roles of mtDNA Mutations in PCOS-IR: A Review.线粒体DNA突变在多囊卵巢综合征-胰岛素抵抗中的潜在作用:综述
Diabetes Metab Syndr Obes. 2023 Jan 25;16:139-149. doi: 10.2147/DMSO.S393960. eCollection 2023.
Diabetes Care. 2010 Jan;33 Suppl 1(Suppl 1):S11-61. doi: 10.2337/dc10-S011.
4
Extended-release niacin or ezetimibe and carotid intima-media thickness.缓释烟酸或依泽替米贝与颈动脉内膜中层厚度
N Engl J Med. 2009 Nov 26;361(22):2113-22. doi: 10.1056/NEJMoa0907569. Epub 2009 Nov 15.
5
The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome.药物干预对多囊卵巢综合征血脂谱的影响。
Obes Rev. 2009 Jul;10(4):431-41. doi: 10.1111/j.1467-789X.2009.00588.x. Epub 2009 Apr 21.
6
Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates.不同脂肪、蛋白质和碳水化合物组成的减肥饮食的比较。
N Engl J Med. 2009 Feb 26;360(9):859-73. doi: 10.1056/NEJMoa0804748.
7
The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study.阿托伐他汀对多囊卵巢综合征患者的影响:一项随机双盲安慰剂对照研究。
J Clin Endocrinol Metab. 2009 Jan;94(1):103-8. doi: 10.1210/jc.2008-1750. Epub 2008 Oct 21.
8
Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.盐酸考来维仑治疗接受二甲双胍治疗的2型糖尿病患者:对血糖和血脂的影响
Arch Intern Med. 2008 Oct 13;168(18):1975-83. doi: 10.1001/archinte.168.18.1975.
9
The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials.在两项随机、安慰剂对照临床试验中,二甲双胍、口服避孕药及生活方式改变对肥胖青春期多囊卵巢综合征女性的影响。
J Clin Endocrinol Metab. 2008 Nov;93(11):4299-306. doi: 10.1210/jc.2008-0461. Epub 2008 Aug 26.
10
Cardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights.多囊卵巢综合征中的心脏代谢异常:药物治疗见解
Pharmacol Ther. 2008 Sep;119(3):223-41. doi: 10.1016/j.pharmthera.2008.04.009. Epub 2008 Jun 17.